Janus Henderson Group PLC Gsk PLC Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $372,820 - $434,477	-9,589 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$38.79 - $43.16 $371,957 - $413,861	9,589 New	9,589 $366,000
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $316,737 - $359,582	-8,673 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $29,095 - $33,968	849 Added 10.85%	8,673 $310,000
Q4 2020 Feb 16, 2021	BUY	$34.07 - $39.94 $266,563 - $312,490	7,824 New	7,824 $288,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.